the importance of a biomarker-directed approach in triple-negative breast cancer
Published 2 years ago • 849 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:42
biomarker-driven therapies for triple-negative breast cancer
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
6:45
innovative biomarker approaches in breast cancer therapy
-
1:55
predictive biomarkers in breast cancer
-
1:45
identifying novel predictive biomarkers in breast cancer
-
0:55
prognostic biomarkers of immunotherapy efficacy in breast cancer
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
1:04
future directions in triple-negative breast cancer research
-
10:07
importance of biomarkers when evaluating heterogeneity in her2 metastatic bc
-
3:22
pten protein and gene expression as a biomarker in breast cancer
-
2:13
changes in tumour biomarkers after neoadjuvant chemotherapy in breast cancer
-
4:13
where does immuno-oncology fit in the treatment landscape of tnbc?
-
1:29
lig1 deletion predicts chemotherapy resistance in triple-negative breast cancer
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
2:26
how biomarker testing can guide metastatic breast cancer treatment | jen heatherly
-
16:02
triple negative breast cancer: immunotherapies and biomarkers
-
2:26
micrornas as a biomarker of resistance to trastuzumab in gec
-
11:23
introduction: biomarkers in breast cancer